TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $960M (100.0% shares, 0.0% debt)

Holdings (32)

CGON CG ONCOLOGY, INC. 12.1%

Value $116M Shares 3,670,206 Share Price $31.57 * Est. Cost/Share $40.67 Unrealized @ Report Date -14.8%

DYN DYNE THERAPEUTICS, INC 9.7%

Value $93.52M Shares 2,650,150 Share Price $35.29 * Est. Cost/Share $16.62 Unrealized @ Report Date +74.8%

ABVX Abivax SA 8.3%

Value $80.07M Shares 6,056,596 Share Price $13.22 Est. Cost/Share $12.76 Unrealized @ Report Date —

SLN SILENCE THERAPEUTICS PLC 6.5%

Value $62.61M Shares 3,295,350 Share Price $19.00 Est. Cost/Share $14.21 Unrealized @ Report Date —

COGT COGENT BIOSCIENCES INC 6.1%

Value $58.71M Shares 6,964,375 Share Price $8.43 * Est. Cost/Share $9.05 Unrealized @ Report Date -16.2%

SVRA SAVARA INC. 5.2%

Value $49.82M Shares 12,362,205 Share Price $4.03 * Est. Cost/Share $3.73 Unrealized @ Report Date +19.2%

MDGL MADRIGAL PHARMACEUTICALS INC 4.4%

Value $41.82M Shares 149,283 Share Price $280.16 * Est. Cost/Share $110.42 Unrealized @ Report Date +115.6%

EWTX EDGEWISE THERAPEUTICS, INC. 4.3%

Value $40.93M Shares 2,272,728 Share Price $18.01 * Est. Cost/Share $15.89 Unrealized @ Report Date +9.7%

KROS KEROS THERAPEUTICS, INC. 4.2%

Value $40.19M Shares 879,344 Share Price $45.70 * Est. Cost/Share $59.30 Unrealized @ Report Date -9.4%

MLYS MINERALYS THERAPEUTICS, INC. 3.9%

Value $37.27M Shares 3,185,185 Share Price $11.70 * Est. Cost/Share $12.35 Unrealized @ Report Date +2.0%

OCUL OCULAR THERAPEUTIX, INC. 3.8%

Value $36.38M Shares 5,319,148 Share Price $6.84 * Est. Cost/Share $7.10 Unrealized @ Report Date -13.0%

TYRA TYRA BIOSCIENCES INC 3.3%

Value $31.81M Shares 1,989,103 Share Price $15.99 * Est. Cost/Share $12.71 Unrealized @ Report Date +35.5%

KURA KURA ONCOLOGY INC 3.1%

Value $29.31M Shares 1,423,642 Share Price $20.59 Est. Cost/Share $14.54 Unrealized @ Report Date +41.3%

GPCR STRUCTURE THERAPEUTICS INC 2.8%

Value $27.27M Shares 694,547 Share Price $39.27 Est. Cost/Share $43.22 Unrealized @ Report Date —

CNTA CENTESSA PHARMACEUTICALS PLC 2.7%

Value $26.1M Shares 2,890,816 Share Price $9.03 Est. Cost/Share $7.22 Unrealized @ Report Date —

— ASTRIA THERAPEUTICS, INC. 2.6%

Value $25.13M Shares 2,761,861 Share Price $9.10 Est. Cost/Share $14.07 Unrealized @ Report Date —

CMPS COMPASS PATHWAYS PLC 2.4%

Value $23.3M Shares 3,858,000 Share Price $6.04 Est. Cost/Share $7.40 Unrealized @ Report Date —

— SOLENO THERAPEUTIVS, INC. 2.3%

Value $22.44M Shares 550,000 Share Price $40.80 Est. Cost/Share $42.80 Unrealized @ Report Date —

IRON Disc Medicine, Inc. 2.3%

Value $21.95M Shares 486,957 Share Price $45.07 * Est. Cost/Share $33.98 Unrealized @ Report Date 0.0%

— TOURMALINE BIO INC 2.0%

Value $19M Shares 1,477,593 Share Price $12.86 Est. Cost/Share $25.14 Unrealized @ Report Date —

TARS TARSUS PHARMACEUTICALS, INC. 1.6%

Value $15.12M Shares 556,317 Share Price $27.18 * Est. Cost/Share $17.70 Unrealized @ Report Date +90.0%

— ADVERUM BIOTECHNOLOGIES, INC. 1.4%

Value $13.78M Shares 2,008,340 Share Price $6.86 Est. Cost/Share $14.14 Unrealized @ Report Date —

— VISTAGEN THERAPEUTICS INC 1.0%

Value $9.314M Shares 2,676,580 Share Price $3.48 Est. Cost/Share $5.14 Unrealized @ Report Date —

TRDA ENTRADA THERAPEUTICS INC 0.9%

Value $8.336M Shares 584,955 Share Price $14.25 Est. Cost/Share $17.12 Unrealized @ Report Date —

EYPT EyePoint Pharmaceuticals, Inc. 0.8%

Value $8.024M Shares 922,335 Share Price $8.70 * Est. Cost/Share $13.97 Unrealized @ Report Date 0.0%

CCCC C4 THERAPEUTICS, INC. 0.6%

Value $5.898M Shares 1,276,574 Share Price $4.62 * Est. Cost/Share $5.83 Unrealized @ Report Date +2.3%

— NEKTAR THERAPEUTICS 0.5%

Value $4.96M Shares 4,000,000 Share Price $1.24 Est. Cost/Share $0.93 Unrealized @ Report Date —

— AEROVATE THERAPEUTICS INC 0.4%

Value $3.72M Shares 2,240,809 Share Price $1.66 Est. Cost/Share $15.50 Unrealized @ Report Date —

ANTX AN2 Therapeutics, Inc. 0.3%

Value $3.344M Shares 1,555,118 Share Price $2.15 * Est. Cost/Share $9.33 Unrealized @ Report Date -74.5%

KOD KODIAK SCIENCES INC 0.2%

Value $2.115M Shares 899,999 Share Price $2.35 * Est. Cost/Share $4.10 Unrealized @ Report Date -17.4%

VTYX VENTYX BIOSCIENCES, INC 0.1%

Value $730K Shares 316,195 Share Price $2.31 * Est. Cost/Share $29.94 Unrealized @ Report Date -86.1%

CABA CABALETTA BIO, INC 0.1%

Value $649K Shares 86,795 Share Price $7.48 * Est. Cost/Share $3.64 Unrealized @ Report Date +236.6%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
CGON	CG ONCOLOGY, INC.	3,670,206	$116M	12.1%	$31.57 *	$40.67	-14.8%	COMM	156944100
DYN	DYNE THERAPEUTICS, INC	2,650,150	$93.52M	9.7%	$35.29 *	$16.62	+74.8%	COMM	26818M108
ABVX	Abivax SA	6,056,596	$80.07M	8.3%	$13.22	$12.76	—	ADRS	00370M103
SLN	SILENCE THERAPEUTICS PLC	3,295,350	$62.61M	6.5%	$19.00	$14.21	—	ADRS	82686Q101
COGT	COGENT BIOSCIENCES INC	6,964,375	$58.71M	6.1%	$8.43 *	$9.05	-16.2%	COMM	19240Q201
SVRA	SAVARA INC.	12,362,205	$49.82M	5.2%	$4.03 *	$3.73	+19.2%	COMM	805111101
MDGL	MADRIGAL PHARMACEUTICALS INC	149,283	$41.82M	4.4%	$280.16 *	$110.42	+115.6%	COMM	558868105
EWTX	EDGEWISE THERAPEUTICS, INC.	2,272,728	$40.93M	4.3%	$18.01 *	$15.89	+9.7%	COMM	28036F105
KROS	KEROS THERAPEUTICS, INC.	879,344	$40.19M	4.2%	$45.70 *	$59.30	-9.4%	COMM	492327101
MLYS	MINERALYS THERAPEUTICS, INC.	3,185,185	$37.27M	3.9%	$11.70 *	$12.35	+2.0%	COMM	603170101
OCUL	OCULAR THERAPEUTIX, INC.	5,319,148	$36.38M	3.8%	$6.84 *	$7.10	-13.0%	COMM	67576A100
TYRA	TYRA BIOSCIENCES INC	1,989,103	$31.81M	3.3%	$15.99 *	$12.71	+35.5%	COMM	90240B106
KURA	KURA ONCOLOGY INC	1,423,642	$29.31M	3.1%	$20.59	$14.54	+41.3%	COMM	50127T109
GPCR	STRUCTURE THERAPEUTICS INC	694,547	$27.27M	2.8%	$39.27	$43.22	—	ADRS	86366E106
CNTA	CENTESSA PHARMACEUTICALS PLC	2,890,816	$26.1M	2.7%	$9.03	$7.22	—	COMM	152309100
—	ASTRIA THERAPEUTICS, INC.	2,761,861	$25.13M	2.6%	$9.10	$14.07	—	COMM	04635X102
CMPS	COMPASS PATHWAYS PLC	3,858,000	$23.3M	2.4%	$6.04	$7.40	—	ADRS	20451W101
—	SOLENO THERAPEUTIVS, INC.	550,000	$22.44M	2.3%	$40.80	$42.80	—	COMM	834203200
IRON	Disc Medicine, Inc.	486,957	$21.95M	2.3%	$45.07 *	$33.98	0.0%	COMM	254604101
—	TOURMALINE BIO INC	1,477,593	$19M	2.0%	$12.86	$25.14	—	COMM	89157D105
TARS	TARSUS PHARMACEUTICALS, INC.	556,317	$15.12M	1.6%	$27.18 *	$17.70	+90.0%	COMM	87650L103
—	ADVERUM BIOTECHNOLOGIES, INC.	2,008,340	$13.78M	1.4%	$6.86	$14.14	—	COMM	00773U108
—	VISTAGEN THERAPEUTICS INC	2,676,580	$9.314M	1.0%	$3.48	$5.14	—	COMM	92840H202
TRDA	ENTRADA THERAPEUTICS INC	584,955	$8.336M	0.9%	$14.25	$17.12	—	COMM	29384C108
EYPT	EyePoint Pharmaceuticals, Inc.	922,335	$8.024M	0.8%	$8.70 *	$13.97	0.0%	COMM	30233G209
CCCC	C4 THERAPEUTICS, INC.	1,276,574	$5.898M	0.6%	$4.62 *	$5.83	+2.3%	COMM	12529R107
—	NEKTAR THERAPEUTICS	4,000,000	$4.96M	0.5%	$1.24	$0.93	—	COMM	640268108
—	AEROVATE THERAPEUTICS INC	2,240,809	$3.72M	0.4%	$1.66	$15.50	—	COMM	008064107
ANTX	AN2 Therapeutics, Inc.	1,555,118	$3.344M	0.3%	$2.15 *	$9.33	-74.5%	COMM	037326105
KOD	KODIAK SCIENCES INC	899,999	$2.115M	0.2%	$2.35 *	$4.10	-17.4%	COMM	50015M109
VTYX	VENTYX BIOSCIENCES, INC	316,195	$730K	0.1%	$2.31 *	$29.94	-86.1%	COMM	92332V107
CABA	CABALETTA BIO, INC	86,795	$649K	0.1%	$7.48 *	$3.64	+236.6%	COMM	12674W109